Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
AGN > SEC Filings for AGN > Form 8-K on 1-May-2013All Recent SEC Filings

Show all filings for ALLERGAN INC | Request a Trial to NEW EDGAR Online Pro



Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders.

Allergan, Inc. (the "Company") held its Annual Meeting of Stockholders on April 30, 2013 (the "Annual Meeting") and there were 264,251,587 votes present in person or by proxy, representing approximately 88.77% of the total outstanding eligible votes. At the Annual Meeting, the Company's stockholders:
(i) elected nine directors to the Company's board of directors; (ii) ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2013; (iii) approved the compensation of the Company's named executive officers; (iv) approved the amendment and restatement of the Company's Amended and Restated Certificate of Incorporation; and (v) rejected two non-binding stockholder proposals, each as more fully described below.

                                              For             Against          Abstain         Non-Votes

Item No. 1: Election of nine directors
to serve for a term of office expiring
at the 2014 annual meeting of
stockholders and until their
successors are duly elected and

David E.I. Pyott                           239,924,816        10,939,077        1,679,374       11,708,320
Michael R. Gallagher                       247,268,744         5,024,015          250,508       11,708,320
Deborah Dunsire, M.D.                      248,263,071         4,034,925          245,271       11,708,320
Dawn Hudson                                248,709,193         3,592,169          241,905       11,708,320
Trevor M. Jones, Ph.D.                     248,197,457         4,094,361          251,449       11,708,320
Louis J. Lavigne, Jr.                      248,810,879         3,480,119          252,269       11,708,320
Peter J. McDonnell, M.D.                   250,656,059         1,637,750          249,458       11,708,320
Timothy D. Proctor                         251,115,689         1,181,168          246,410       11,708,320
Russell T. Ray                             248,722,898         3,573,330          247,039       11,708,320

Item No. 2: Ratification of the            262,330,744         1,538,802          382,041                0
appointment of Ernst & Young LLP as
the Company's independent registered
public accounting firm for fiscal year

Item No. 3: Advisory vote to approve       231,178,665        19,672,763        1,691,839       11,708,320
the compensation of the Company's
named executive officers

Item No. 4: Approval of the Amendment      251,448,907           728,924          365,436       11,708,320
and Restatement of our Amended and
Restated Certificate of Incorporation

Item No. 5: Stockholder Proposals*
Stockholder Proposal # 1 (Right to Act
by Written Consent)                        126,004,402       125,198,362        1,340,503       11,708,320
Stockholder Proposal # 2 (Disclosure
of Lobbying Practices)                      62,737,911       150,171,740       39,633,616       11,708,320

* Approval of the non-binding stockholder proposals requires the affirmative vote of a majority of the shares present at the Annual Meeting, in person or by proxy, and entitled to vote. Abstentions represent shares present at the Annual Meeting and entitled to vote; therefore, abstentions have the same effect as votes against the stockholder proposals.

  Add AGN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for AGN - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.